Our report of novel NRG1 gene rearrangements detected in serous carcinomas of the ovary, fallopian tube, and peritoneum indicates a small, but important prevalence of these fusions occurring within the female genital tract. The gene discussed is NRG1; the disease is serous adenocarcinoma.